Anti-Inflammatory Therapeutics Market

Anti-Inflammatory Therapeutics Market (Drug Class: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Biologics and Others; Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease (IBD), and Other Anti-inflammatory diseases; Route of Administration: Oral, Topical, Injectable, Inhalation and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026–2036

Anti-Inflammatory Therapeutics Market Outlook 2036

The global anti-inflammatory therapeutics market size was valued at USD 111.4 Billion in 2025 and is projected to reach USD 213.4 Billion by 2036, expanding at a CAGR of 6.1% from 2026 to 2036. The anti-inflammatory therapeutics market is driven by the rising prevalence of chronic inflammatory diseases such as arthritis, asthma, and inflammatory bowel disorders, which is increasing the long-term demand for effective treatment options. Additionally, growing aging populations and advancements in biologics and targeted therapies are further accelerating market growth.

Market Size & Highlights

The anti-inflammatory therapeutics market reached USD 111.4 Billion in 2025.
The market is expected to climb to USD 213.4 Billion by 2036.
The industry is anticipated to expand at a CAGR of 6.1% from 2026 to 2036.
The major companies in the market include Eli Lilly, AstraZeneca, F. Hoffmann-La Roche, Johnson & Johnson, Amgen, Pfizer, etc.
North America dominated the anti-inflammatory therapeutics market in 2025, holding the largest revenue share of 37.3%
By Indications, Arthritis segment accounted for the largest share of 32.6% in 2025.

Anti Inflammatory Therapeutics Market By Revenue

Analysts’ Viewpoint

The anti-inflammatory therapeutics market is witnessing steadiness due to increasing prevalence of chronic diseases, rising aging population, and continuous innovation in biologics therapies development. The market demonstrates a strong potential for growth due to rising healthcare expenditures, improved diagnostic understanding, and increasing use of targeted medical therapies in the major areas. Pharmaceutical companies have three main strategic areas that they use to build their competitive advantage through collaborative research efforts, new product development, and biosimilar product creation.

The expanding healthcare systems in the emerging markets along with their improved treatment access and increasing government healthcare support programs create attractive business opportunities for companies. Patients who want to receive long-term treatment that produces effective results with minimal side-effects are driving research for safer targeted medical solutions.

The process of pharmaceutical companies establishing strategic mergers and acquisitions together with partnerships leads to faster product development and wider market access across both - developed and developing markets. The overall market forecast shows positive trends due to increasing patient numbers, advancements in technology, and ongoing efforts to enhance life quality results.

Market Introduction

Anti-inflammatory agents are defined as substances that help limit the harmful consequences of excessive inflammation while preserving its beneficial effects. Common examples include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, biologics, etc.

Attribute	Detail
Market Drivers	Rising prevalence of chronic inflammatory diseases Strong R&D investments by pharmaceutical companies

Rising Prevalence of Chronic Inflammatory Diseases Expected to Drive Anti-Inflammatory Therapeutics Market Size

The rising prevalence of chronic inflammatory diseases is visibly increasing the global demand for effective anti-inflammatory therapeutics across healthcare systems. The global population needs ongoing treatment for asthma, rheumatoid arthritis, psoriasis, and inflammatory bowel disease as such medical conditions require continuous medication.

Patients who learn about early diagnosis and treatment options display increased interest in obtaining medical assistance that includes anti-inflammatory medications. The combination of urbanization, changing lifestyles, and rising environmental pollution levels leads to an increase in frequency of diseases linked to inflammation, which results in a continuous need for medical treatment.

The healthcare industry focuses on chronic condition management, which results in increased prescription activities for anti-inflammatory medications. The elderly population globally faces higher risks of developing chronic inflammatory diseases, which forces them to rely on drugs for extended period of symptom control.

Drug companies dedicate substantial resources to research and development programs that aim to develop new anti-inflammatory treatments that provide improved safety and treatment results. Developing nations experience rising healthcare costs that enable patients to access improved medical treatments while driving growth in the anti-inflammatory drug market.

Strong R&D Investments by Pharmaceutical Companies Anticipated to Boost Anti-Inflammatory Therapeutics Market Expansion

Strong research and development investments by pharmaceutical companies are playing a vital role in advancing the anti-inflammatory therapeutics market growth. The process of drug discovery stays active as researchers continue to create new anti-inflammatory drugs that treat patients more safely and effectively while reducing their health hazards.

Pharmaceutical companies direct their research efforts toward developing biologic medicines and targeted therapies, which deliver improved treatment results to patients battling chronic inflammatory diseases. Healthcare providers throughout the globe now have improved treatment options as these new treatments enable doctors to prescribe advanced anti-inflammatory medicines with greater assurance.

The increasing number of clinical trials together with research partnerships is speeding up the development of new therapeutic molecules that aim to treat complex inflammatory disease pathways. Pharmaceutical companies allocate their financial resources to create product pipelines that enable them to compete in the fast changing pharmaceutical market.

Scientists use biotechnology and molecular research techniques to discover new drug targets which enhance treatment accuracy and treatment results. Pharmaceutical companies are forming more partnerships with research institutions to create innovative treatments through research material sharing. The availability of new anti-inflammatory medications which receive regulatory approval boosts market growth as it helps to expand treatment options for patients. The expansion of research activities is likely to lead to the development of new treatments, which will create substantial growth in the market

Attribute	Detail
Market Opportunity	Untapped potential in rare inflammatory diseases

Untapped Potential in Rare Inflammatory Diseases Presents Significant Opportunity for Anti-Inflammatory Therapeutics Market

Untapped potential in rare inflammatory diseases presents a significant growth opportunity for the anti-inflammatory therapeutics market across the global healthcare industries. The global market currently witnesses a higher demand for new treatment methods and specialized drug products as many rare inflammatory disorders currently lack effective treatment solutions.

The rising interest in studying rare autoimmune and inflammatory diseases has prompted the pharmaceutical companies to actively seek new opportunities for developing drugs. Orphan drug designations serve as government incentives, which drive companies to dedicate research resources toward developing new treatments for rare inflammatory diseases. The application of advanced diagnostic methods now allows healthcare professionals to identify rare diseases at earlier stages, thereby expanding the global reach of their treatment programs.

The biotechnology and genomics fields have made progress that enables scientists to create targeted therapies treating rare inflammatory diseases. The limited number of approved treatments creates a market opportunity for pharmaceutical companies to build their market share and establish themselves as industry leaders across international markets. High awareness among healthcare providers and patients leads to improved recognition of rare diseases, which helps patients receive medical treatment.

Arthritis Segment Driving Anti-Inflammatory Therapeutics Market Growth

Anti Inflammatory Therapeutics Market By Type

The anti-inflammatory therapeutics market sees its largest market share through arthritis treatments as arthritis has high global occurrence rates and patients need ongoing medical care.

Patients with arthritis need continuous medical treatment, which results in stable medication usage that helps businesses maintain consistent revenue flow. The development of biologics together with targeted pharmaceuticals has led to better treatment results that persuade doctors to use contemporary anti-inflammatory medicine.

The rising public awareness about early arthritis detection and treatment methods leads to increased anti-inflammatory medicine prescription, which drives market expansion. The increased healthcare spending in all nations enables improved access to arthritis treatments and extended disease management solutions. The anti-inflammatory therapeutics market sees its highest demand through arthritis treatment as patients need continuous medical care.

Regional Outlook of Anti-Inflammatory Therapeutics Market

Anti Inflammatory Therapeutics Market By Region

Attribute	Detail
Leading Region	North America

North America dominates the anti-inflammatory therapeutics industry, accounting for a considerable 37.3% market share. The region experiences increased incidences of chronic inflammatory disease cases, which include asthma, arthritis, and inflammatory bowel diseases that need ongoing medical treatment. The rising number of elderly people in the United States and Canada creates an annual increase in demand for efficient anti-inflammatory treatments. The regional pharmaceutical industry’s presence drives innovation, which enables drug development and fast market entry of new anti-inflammatory biologics and therapies.

The combination of reimbursement systems and insurance protections enables patients to obtain innovative therapies, which results in steady income streams and broad product usage. The early implementation of biologics, biosimilars, and targeted therapies improves medical results while expanding market access for hospitals, clinics, and specialty centers. The increased understanding of early diagnosis together with disease management practices leads to higher treatment rates while driving the demand for prescription anti-inflammatory medications.

Ongoing clinical research investments and development activities lead to new product development while North America increases its international market competitiveness. Government backing together with regulatory approvals and healthcare provider-manufacturer partnerships improve patient access to modern treatment options. North America retains its market dominance through superior infrastructure systems and high public treatment knowledge and ongoing research progress in anti-inflammatory therapeutic development.

Analysis of Key Players in Anti-Inflammatory Therapeutics Market

Eli Lilly and Company, AstraZeneca, F. Hoffmann-La Roche AG, Johnson & Johnson and its affiliates, Amgen Inc., Pfizer Inc., GSK plc, Novartis AG, Merck & Co., Inc., Dr. Reddy’s Laboratories, AdvaCare Pharma, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd. are the key players governing the global Anti-Inflammatory Therapeutics Market.

Each of these players has been profiled in the anti-inflammatory therapeutics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Anti-Inflammatory Therapeutics Market

In April 2025, Strides Pharma received approval for celecoxib capsules, 100 mg, 200 mg, and 400 mg, from the United States Food & Drug Administration (FDA). The approval of celecoxib capsules strengthens Strides’ portfolio in the anti-inflammatory therapeutic segment.
In February 2025, Kiora Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office had issued a composition-of-matter patent (US-12209073-B2) on a specific crystalline form, or polymorph of KIO-104. KIO-104 is a novel, non-steroidal anti-inflammatory, small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
In April 2024, Glenmark Pharmaceuticals received approval from the U.S. health regulator to sell a generic version of anti-inflammatory drug in the North America market.

Anti-Inflammatory Therapeutics Market Snapshot

Attribute	Detail
Size in 2025	USD 111.4 Billion
Forecast Value in 2036	More than USD 213.4 Billion
CAGR	6.1%
Forecast Period	2026-2036
Historical Data Available for	2021-2025
Quantitative Units	USD Billion for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Drug Class Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Corticosteroids Biologics Others (DMARDs, analgesics, etc.) Indication Arthritis Respiratory Diseases Multiple Sclerosis Psoriasis Inflammatory Bowel Disease (IBD) Others Route of Administration Oral Topical Injectable Inhalation Others (Transdermal, etc.) Distribution Channel Hospital pharmacies Retail pharmacies Online pharmacies
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China India Japan South Korea Australia ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	Eli Lilly and Company AstraZeneca F. Hoffmann-La Roche Ltd Johnson & Johnson and its affiliates Amgen Inc. Pfizer Inc. GSK plc Novartis AG Merck & Co., Inc. Dr. Reddy’s Laboratories AdvaCare Pharma Viatris Inc. Teva Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. Other Prominent Players
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global anti-inflammatory therapeutics market in 2025?

The market was valued at USD 111.4 Billion in 2025

What is the projected size of the anti-inflammatory therapeutics industry by 2036?

The market is projected to reach USD 213.4 Billion by the end of 2036

What are the factors driving the anti-inflammatory therapeutics market?

Rising prevalence of chronic inflammatory diseases and strong R&D investments by pharmaceutical companies

What is the anti-inflammatory therapeutics market expected to grow during the forecast period?

It is anticipated to grow at a CAGR 6.1% from 2026 to 2036

Which region is expected to dominate the anti-inflammatory therapeutics market during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

Who are the prominent anti-inflammatory therapeutics providers?

Eli Lilly and Company, AstraZeneca, F. Hoffmann-La Roche Ltd, Johnson & Johnson and its affiliates, Amgen Inc., Pfizer Inc., GSK plc, Novartis AG, Merck & Co., Inc., Dr. Reddy’s Laboratories, AdvaCare Pharma, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and others

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Anti-Inflammatory Therapeutics Market
Market Overview
- Introduction
  - Segment Definition
  - Industry Evolution / Developments
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Anti-Inflammatory Therapeutics Market Analysis and Forecast, 2021-2036
  - Market Revenue Projections (US$ Bn)
Key Insights
- Healthcare Expenditure by Country/Region
- Recent Technological Advancements
- Regulatory Scenario across Key Countries / Regions
- PORTER’s Five Forces Analysis
- Consumer Behavior & End-User Insights
- PESTLE Analysis
- Key Industry Events
- Go to Marketing Strategies for New Entrants
- Pricing Analysis
- Distributors Landscape
Global Anti-Inflammatory Therapeutics Market Analysis and Forecast, by Drug Class
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Attractiveness Analysis, by Drug Class
Global Anti-Inflammatory Therapeutics Market Analysis and Forecast, by Indication
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Attractiveness Analysis, by Indication
Global Anti-Inflammatory Therapeutics Market Analysis and Forecast, by Route of Administration
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Attractiveness Analysis, by Route of Administration
Global Anti-Inflammatory Therapeutics Market Analysis and Forecast, by Distribution Channel
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis, by Distribution Channel
Global Anti-Inflammatory Therapeutics Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2021-2036
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country, 2021-2036
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
  - By Country
U.S. Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Canada Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Europe Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
Germany Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
U.K. Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
France Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Italy Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Spain Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
The Netherlands Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Rest of Europe Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Asia Pacific Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - China
  - India
  - Japan
  - South Korea
  - Australia
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
China Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
India Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Japan Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
South Korea Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Australia Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
ASEAN Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Latin America Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
Brazil Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Mexico Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Argentina Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Rest of Latin America Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Middle East & Africa Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
GCC Countries Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
South Africa Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Rest of Middle East & Africa Anti-Inflammatory Therapeutics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Drug Class, 2021-2036
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Corticosteroids
  - Biologics
  - Others
- Market Value Forecast, by Indication, 2021-2036
  - Arthritis
  - Respiratory Diseases
  - Multiple Sclerosis
  - Psoriasis
  - Inflammatory Bowel Disease (IBD)
  - Others
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Topical
  - Injectable
  - Inhalation
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Drug Class
  - By Indication
  - By Route of Administration
  - By Distribution Channel
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2025)
- Company Profiles
  - Eli Lilly and Company
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - AstraZeneca
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - F. Hoffmann-La Roche Ltd
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Johnson & Johnson and its affiliates
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Amgen Inc
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Pfizer Inc
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - GSK plc
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Novartis AG
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Merck & Co., Inc
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Dr. Reddy’s Laboratories
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - AdvaCare Pharma
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Viatris Inc
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Teva Pharmaceutical Industries Ltd.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Sun Pharmaceutical Industries Ltd.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments

List of Figures

Figure 01: Global Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 02: Global Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 03: Global Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 04: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Nonsteroidal Anti-inflammatory Drugs (NSAIDs), 2021 to 2036
Figure 05: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Corticosteroids, 2021 to 2036
Figure 06: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Biologics, 2021 to 2036
Figure 07: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 08: Global Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 09: Global Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 10: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Arthritis, 2021 to 2036
Figure 11: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Respiratory Diseases, 2021 to 2036
Figure 12: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Multiple Sclerosis, 2021 to 2036
Figure 13: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Psoriasis, 2021 to 2036
Figure 14: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Inflammatory Bowel Disease (IBD), 2021 to 2036
Figure 15: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 16: Global Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 17: Global Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 18: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Oral, 2021 to 2036
Figure 19: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Topical, 2021 to 2036
Figure 20: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Injectable, 2021 to 2036
Figure 21: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Inhalation, 2021 to 2036
Figure 22: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 23: Global Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 24: Global Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 25: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Hospital Pharmacies, 2021 to 2036
Figure 26: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Retail Pharmacies, 2021 to 2036
Figure 27: Global Anti-Inflammatory Therapeutics Market Revenue (US$ Bn), by Online Pharmacies, 2021 to 2036
Figure 28: Global Anti-Inflammatory Therapeutics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 29: Global Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 30: North America Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 31: North America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 32: North America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 33: North America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 34: North America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 35: North America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 36: North America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 37: North America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 38: North America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 39: North America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 40: North America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 41: U.S. Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 42: U.S. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 43: U.S. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 44: U.S. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 45: U.S. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 46: U.S. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 47: U.S. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 48: U.S. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 49: U.S. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 50: Canada Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 51: Canada Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 52: Canada Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 53: Canada Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 54: Canada Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 55: Canada Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 56: Canada Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 57: Canada Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 58: Canada Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 59: Europe Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 60: Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 61: Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 62: Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 63: Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 64: Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 65: Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 66: Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 67: Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 68: Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 69: Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 70: Germany Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 71: Germany Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 72: Germany Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 73: Germany Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 74: Germany Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 75: Germany Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 76: Germany Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 77: Germany Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 78: Germany Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 79: U.K. Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 80: U.K. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 81: U.K. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 82: U.K. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 83: U.K. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 84: U.K. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 85: U.K. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 86: U.K. Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 87: U.K. Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 88: France Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 89: France Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 90: France Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 91: France Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 92: France Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 93: France Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 94: France Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 95: France Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 96: France Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 97: Italy Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 98: Italy Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 99: Italy Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 100: Italy Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 101: Italy Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 102: Italy Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 103: Italy Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 104: Italy Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 105: Italy Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 106: Spain Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 107: Spain Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 108: Spain Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 109: Spain Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 110: Spain Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 111: Spain Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 112: Spain Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 113: Spain Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 114: Spain Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 115: The Netherlands Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 116: The Netherlands Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 117: The Netherlands Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 118: The Netherlands Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 119: The Netherlands Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 120: The Netherlands Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 121: The Netherlands Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 122: The Netherlands Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 123: The Netherlands Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 124: Rest of Europe Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 125: Rest of Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 126: Rest of Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 127: Rest of Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 128: Rest of Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 129: Rest of Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 130: Rest of Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 131: Rest of Europe Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 132: Rest of Europe Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 133: Asia Pacific Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 134: Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 135: Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 136: Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 137: Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 138: Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 139: Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 140: Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 141: Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 142: Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 143: Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 144: China Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 145: China Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 146: China Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 147: China Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 148: China Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 149: China Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 150: China Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 151: China Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 152: China Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 153: Japan Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 154: Japan Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 155: Japan Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 156: Japan Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 157: Japan Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 158: Japan Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 159: Japan Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 160: Japan Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 161: Japan Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 162: India Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 163: India Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 164: India Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 165: India Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 166: India Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 167: India Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 168: India Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 169: India Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 170: India Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 171: South Korea Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 172: South Korea Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 173: South Korea Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 174: South Korea Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 175: South Korea Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 176: South Korea Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 177: South Korea Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 178: South Korea Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 179: South Korea Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 180: Australia Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 181: Australia Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 182: Australia Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 183: Australia Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 184: Australia Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 185: Australia Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 186: Australia Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 187: Australia Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 188: Australia Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 189: ASEAN Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 190: ASEAN Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 191: ASEAN Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 192: ASEAN Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 193: ASEAN Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 194: ASEAN Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 195: ASEAN Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 196: ASEAN Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 197: ASEAN Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 198: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 199: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 200: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 201: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 202: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 203: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 204: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 205: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 206: Rest of Asia Pacific Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 207: Latin America Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 208: Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 209: Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 210: Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 211: Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 212: Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 213: Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 214: Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 215: Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 216: Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 217: Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 218: Brazil Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 219: Brazil Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 220: Brazil Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 221: Brazil Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 222: Brazil Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 223: Brazil Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 224: Brazil Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 225: Brazil Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 226: Brazil Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 227: Mexico Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 228: Mexico Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 229: Mexico Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 230: Mexico Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 231: Mexico Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 232: Mexico Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 233: Mexico Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 234: Mexico Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 235: Mexico Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 236: Argentina Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 237: Argentina Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 238: Argentina Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 239: Argentina Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 240: Argentina Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 241: Argentina Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 242: Argentina Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 243: Argentina Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 244: Argentina Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 245: Rest of Latin America Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 246: Rest of Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 247: Rest of Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 248: Rest of Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 249: Rest of Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 250: Rest of Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 251: Rest of Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 252: Rest of Latin America Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 253: Rest of Latin America Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 254: Middle East and Africa Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 255: Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 256: Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 257: Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 258: Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 259: Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 260: Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 261: Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 262: Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 263: Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 264: Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 265: GCC Countries Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 266: GCC Countries Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 267: GCC Countries Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 268: GCC Countries Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 269: GCC Countries Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 270: GCC Countries Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 271: GCC Countries Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 272: GCC Countries Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 273: GCC Countries Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 274: South Africa Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 275: South Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 276: South Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 277: South Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 278: South Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 279: South Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 280: South Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 281: South Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 282: South Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036
Figure 283: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 284: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Drug Class, 2025 and 2036
Figure 285: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Drug Class, 2026 to 2036
Figure 286: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Indication, 2025 and 2036
Figure 287: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Indication, 2026 to 2036
Figure 288: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Route of Administration, 2025 and 2036
Figure 289: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Route of Administration, 2026 to 2036
Figure 290: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Value Share Analysis, by Distribution Channel, 2025 and 2036
Figure 291: Rest of Middle East and Africa Anti-Inflammatory Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2026 to 2036